Dimethyl Fumarate

證據等級: L5

預測適應症: 0 個

DIMETHYL FUMARATE: Evidence Pack Incomplete — Evaluation on Hold

One-Sentence Summary

DIMETHYL FUMARATE (DrugBank ID: DB08908) is a drug currently not marketed in Taiwan, with no original indications recorded in this Evidence Pack. The TxGNN model has not generated any predicted new indications for this candidate at this time, and critical data including mechanism of action and safety warnings remain unavailable. This report documents the current data status and outlines the remediation steps required before a repurposing evaluation can proceed.

Quick Overview

Item	Content
Original Indication	Not available in this Evidence Pack
Predicted New Indication	None generated by TxGNN
TxGNN Prediction Score	N/A
Evidence Level	L5 — No predictions or supporting studies available
Taiwan Market Status	Not marketed (未上市)
Number of Authorizations	0
Recommended Decision	Hold

Why Evaluation Cannot Proceed

This Evidence Pack is missing the two foundational inputs required for a repurposing evaluation:

1. No TxGNN Predictions Available The predicted_indications field is empty. Without at least one candidate indication from the TxGNN model, there is no repurposing hypothesis to evaluate. This may indicate that the drug's knowledge graph representation is incomplete, or that the model did not identify statistically significant disease–drug links above the scoring threshold.

2. Mechanism of Action Unavailable The MOA field was not populated from DrugBank during the pipeline run. Although DrugBank returned a successful query result (query log ID: 3), the structured MOA data was not captured. This blocks mechanistic plausibility analysis — a required step in the evaluation workflow.

3. Safety Data Unavailable Key warnings and contraindications from the TFDA package insert were not resolved despite a successful tfda_package_insert query (query log ID: 4). Without safety data, the S1 safety pre-screening cannot be completed.

Taiwan Market Information

No authorizations on record. DIMETHYL FUMARATE has not been approved or marketed in Taiwan as of the data cutoff date (2026-04-20).

Safety Considerations

Please refer to the package insert for safety information. No drug–drug interaction data was found in the DDI database (query log ID: 2, status: not_found).

Conclusion and Next Steps

Decision: Hold

Rationale: The Evidence Pack contains no TxGNN-predicted indications and is missing both mechanism of action and safety data. A repurposing evaluation cannot be meaningfully conducted without a target indication to assess.

To proceed, the following is needed:

Re-run TxGNN prediction pipeline for DB08908 and verify that the drug node exists in the knowledge graph with sufficient edge coverage; if the node is absent or under-represented, supplementary graph embedding may be required before re-running
Retrieve MOA from DrugBank — the API query returned a result but structured MOA fields were not extracted; re-parse the DrugBank response for mechanism-of-action, pharmacodynamics, and targets fields
Parse TFDA package insert — the insert PDF was retrieved (query log ID: 4) but warnings and contraindications were not extracted; re-run the PDF parser and populate safety.key_warnings and safety.contraindications
Confirm original approved indications — cross-reference EMA, FDA, and PMDA databases to populate original_indications and support the TxGNN training signal
Once the above gaps are resolved, re-generate the Evidence Pack and re-submit for a full repurposing evaluation
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.